- South San Francisco CA, US Joyce James - Oakland CA, US M. Scott Harris - Takoma Park MD, US
Assignee:
Lyric Pharmaceuticals Inc. - South San Francisco CA
International Classification:
A61K 38/12 A61K 9/00
Abstract:
Enteral Feeding Intolerance (EFI) can be efficaciously treated by administration of therapeutically effective doses of ulimorelin every 8 hours (three times a day). Therapeutic benefit can be obtained from single and consecutive daily dosing, including for periods of up to a week or longer.
FREE ONE STOP SHOPPING MALL IN THE COMFORT OF YOUR OWN HOME. ALL YOUR FAVORITE BRAND NAME STORES, EARN CASH AN DISCOUNTS FOR JUST SHOPPING ON LINE FROM YOUR FREE AGENT WEBSITE JUST FOLLOW THE INSTRU...